Opinion

  • How can NHS diagnostic imaging adopt AI more quickly?

    More patients than ever are waiting for diagnostic imaging, meaning AI is urgently needed. Dr Rhidian Bramley, consultant radiologist at The Christie NHS Foundation Trust, and diagnostics, digital & innovation clinical lead for the Greater Manchester Cancer Alliance, explains how his region has the means to implement AI at-scale and at-pace.  Computer scientist Geoffrey Hinton [...]

  • How healthcare must adopt an AI approach to patient engagement

    By James Neal, Chief Revenue Officer at EBO Artificial intelligence and machine learning are already mainstream tools in many sectors, helping to automate manual tasks, accelerate processes, and drive innovation. In healthcare, the adoption of this technology will make today’s practices seem outdated in just a few years. However, as we scale up these innovations, [...]

  • NHS risks missing healthcare revolution

    Julia Hawkins, general partner at LocalGlobe, considers why patients could miss out on this reform without change in the NHS. Fifty years ago, few could have predicted the profound impact computing would have on our lives. From the first wave of home PCs - with their limited function and purpose, unconnected to the web - [...]

  • Change to NHS payment mechanisms: Accurately coded data will be needed to deliver them

    Lord Darzi’s report on the state of the NHS was concerned about productivity and suggested the re-introduction of payment for activity could improve it. While commentary on the Budget and the coming 10 Year Health Plan has focused on the need for policy and financial incentives to be aligned. Adrian Jones, director - Maxwell Stanley [...]

  • Hospitals and digital health: Saving people and the planet, a 2024 update – take 2

    How leading health systems can be global role models in sustainability, by Gil Bashe, Health Tech World author and FINN chair global health and purpose. The United Nations Conference of the Parties (COP) is held annually, with its Presidency rotating among five recognised UN regions.  Last year, at COP28, world leaders and climate change advocates [...]

  • Analysis: European Medicines Agency issues guidance on AI use in pharma regulatory science

    By Vladimir Murovec, head of life sciences regulatory, Osborne Clarke in Brussels The European Medicines Agency (EMA) and the Heads of Medicines Agencies recently unveiled guiding principles on leveraging large language models (LLMs) within regulatory science and pharmaceutical oversight. These new guidelines, while directed at regulatory authorities, bear implications for pharmaceutical firms and enterprises using or supplying [...]

  • The UK Golden Triangle: a beacon for global health innovation

    By Gil Bashe, Health Tech World author and FINN Partners chair of global health and purpose Few regions in the life sciences landscape shine as brightly as the United Kingdom Golden Triangle, which encompasses London, Oxford, and Cambridge. This easily traversable area hosts a wealth of prestigious universities, world-class research institutions, and a well-established but [...]

  • Comment: How AI is shaping the next era of disease diagnosis

    By Jonathan Bridges, chief innovation officer at Exponential-e. Artificial intelligence (AI) is set to change the field of pathology, transforming how diseases are detected and diagnosed. With its ability to enhance efficiency, accuracy, and the speed of screening, AI can significantly improve the detection of conditions such as breast, bowel, and cervical cancer. As pathology [...]

  • Budget comment: Three areas the gov should be spending on to get the NHS back on track

    The NHS isn’t broken it just needs an MOT and a tune up says Real World Health’s Scott Fletcher. Ahead of October’s budget here’s three areas he thinks the government should be putting money into to get the NHS back on track: 1. Management There’s this perception that anyone who's not contributing at the front line of [...]

  • Comment: Why AI is the key to democratising drug discovery

    By Andrey Doronichev, CEO of AI-focused drug discovery infrastructure company Optic. The global drug development landscape is bustling, with over 20,000 biotechs competing for investor attention. Now more than ever, having a decisive edge is crucial to bring the right molecule from target to lead candidate to approved drug. Fast. Generative AI could be the [...]